Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Investigation|October 17, 2001
Role of AMP-activated protein kinase in mechanism of metformin actionG Zhou, R Myers, Y Li, et al.
Diabetes|May 30, 2006
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetesJames Mu, John Woods, Yun-Ping Zhou, et al.
Molecular Pharmacology|August 23, 2000
Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null miceJ G DeLuca, T W Doebber, L J Kelly, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agentsHiroo Koyama, Julia K Boueres, Daniel J Miller, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2005
Design and synthesis of potent and subtype-selective PPARalpha agonistsRanjit C Desai, Edward Metzger, Conrad Santini, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agentsRanjit C Desai, Wei Han, Edward J Metzger, et al.
Endocrinology|December 1, 1998
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expressionL J Kelly, P P Vicario, G M Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
O-arylmandelic acids as highly selective human PPAR alpha/gamma agonistsAlan D Adams, Zao Hu, Derek von Langen, et al.
Biochemical and Biophysical Research Communications|May 4, 2004
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activitiesThomas W Doebber, Linda J Kelly, Gaochao Zhou, et al.
Diabetes Care|December 19, 2015
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 StudiesChristof M Kazda, Ying Ding, Ronan P Kelly, et al.
Pageof 18